BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11977767)

  • 1. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension.
    Hirono O; Fatema K; Nitobe J; Takeishi Y; Kaneko K; Shiga R; Kubota I
    J Cardiol; 2002 Apr; 39(4):195-204. PubMed ID: 11977767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy.
    Ishikawa J; Kario K; Matsui Y; Shibasaki S; Morinari M; Kaneda R; Hoshide S; Eguchi K; Hojo Y; Shimada K
    Hypertens Res; 2005 Dec; 28(12):995-1001. PubMed ID: 16671339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
    González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
    Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
    Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
    Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
    Török E; Borbás S; Lengyel M; Zorándi A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S79-83. PubMed ID: 1376844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
    Horio T; Kohno M; Yasunari K; Murakawa K; Yokokawa K; Ikeda M; Fukui T; Kano H; Takeda T
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):177-82. PubMed ID: 8032577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension.
    Muneta S; Kohara K; Hiwada K
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):141-7. PubMed ID: 10190762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy.
    Diéz J; Laviades C
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S21-5. PubMed ID: 7807509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of fasting serum insulin in normotensive patients with left ventricular hypertrophy].
    Wang XK; Yang CM; Wang Y; Wang HY; Fu CJ; Fang YQ; Shi WB; Zhang Y; Du WH; Li T
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1048-50. PubMed ID: 15447860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension].
    Cao Y; Zhao SP; Luo L
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):379-81. PubMed ID: 14653122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.